The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing

13 May 2019 07:00

RNS Number : 7437Y
Sabien Technology Group PLC
13 May 2019
 

For immediate release

13 May 2019

 

Sabien Technology Group plc

 ("Sabien" or the "Company")

Placing

 

The Board of Sabien announces that the Company's broker, Peterhouse Capital Limited ("Peterhouse"), has today raised gross proceeds of £300,000 via the placing of 300,000,000 new ordinary shares (the "Placing Shares") with new and existing investors, at a price of 0.1 pence per Placing Share (the "Placing Price") pursuant to the Company's existing share authorities. The Placing is conditional on admission of the Placing Shares to trading on AIM. Following completion of the Placing, the enlarged issued share capital of the Company comprises 890,254,867 New Ordinary Shares of 0.01 pence each. Once issued, the Placing shares will rank pari passu with the Company's existing ordinary shares. Application will be made for the Placing Shares to be admitted to trading on AIM ("Admission") which is expected to become effective on or around 17 May 2019.

 

The proceeds of the Placing will be used to provide additional working capital for the Company and in particular, to finance in the short term, the delivery of the current sales order announced in April this year, and more generally to support sales activities to generate further orders from the sales pipeline outlined in the interim results published on 14 February 2019 and to allow the Board the ability to continue to evaluate additional acquisition and investment opportunities to enhance the long-term value of the Company for shareholders.

 

The Board continues to be very aware that any Placing is dilutive for the existing shareholders and considered whether any pre-emptive offering might be possible, but concluded that it was neither practicable nor cost effective to do so at this time, particularly given current uncertain market conditions and the working capital requirements of the Company. The Board has therefore sought to minimise the impact of dilution on existing shareholders by raising the minimum funding necessary to meet its current and projected needs and by seeking to minimise the discount of the Placing Price to the current market price. Overall, the Placing Price represents a discount of approximately 26% percent to the closing mid-market price of 0.135p per share on 10 May 2019, the last practicable date before proceeding with the Placing. The Placing Shares will represent approximately 33.7% of the enlarged share capital of the Company.

 

Pursuant to the Placing arranged by Peterhouse, Hawk Investments Holdings Limited ("HIHL"), has subscribed for 68,544,000 Placing Shares. HIHL is an existing shareholder interested in 22.85% of the current issued share capital of the Company and its subscription therefore is treated as a related party transaction for the purposes of the AIM Rules. HIHL has subscribed on the same terms and conditions as the other Placees, which have been procured on an arms-length basis by the Company's broker, Peterhouse. The Directors consider, having consulted with the Company's Nominated Adviser, that the terms of HIHL's subscription pursuant to the Placing are fair and reasonable insofar as all shareholders are concerned.

 

Total Voting Rights

In conformity with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority ("FCA"), with effect from 17 May 2019, the Company's issued share capital consists of 890,254,867 Ordinary Shares of 0.01p each with voting rights. The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of Ordinary Shares in the Company with voting rights is 890,254,867.

 

The above figure of 890,254,867 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Special note concerning the Market Abuse Regulation

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014 ("MAR"). Market soundings, as defined in MAR, were taken in respect of the Placing, with the result that certain persons became aware of inside information, as permitted by MAR. That inside information is set out in this announcement. Therefore, those persons that received inside information in a market sounding are no longer in possession of inside information relating to the Company and its securities.

 

The person who arranged for the release of this announcement on behalf of the Company was Alan O'Brien, CEO and Director.

 

For further information:

 

Sabien Technology Group plc

Alan O'Brien

+44(0)20 7993 3700

Beaumont Cornish Limited (Nominated Advisor)

Michael Cornish and Roland Cornish

www.beaumontcornish.com

+44(0)20 7628 3396

Peterhouse Capital Limited (Broker)

Duncan Vasey and Martin Lampshire

+44(0)20 7469 0930

 

 

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEVLLFFKEFBBBE
Date   Source Headline
28th Nov 20185:49 pmRNSNotice of AGM
28th Nov 20185:29 pmRNSAnnual Financial Report
27th Nov 20183:21 pmRNSNotice of GM
23rd Nov 201812:07 pmRNSConditional placing and proposed board changes
19th Nov 20185:47 pmRNSHolding(s) in Company
30th Aug 20184:36 pmRNSResult of Meeting, Change of Registered Office
7th Jun 20187:00 amRNSCorporate Update New Order Received
2nd May 201810:51 amRNSTotal Voting Rights
27th Mar 20184:33 pmRNSPDMR Shareholding
26th Mar 20187:00 amRNSFundraise and appointment of sole broker
15th Mar 20182:42 pmRNSDirector/PDMR Shareholding
28th Feb 20185:34 pmRNSDirector/PDMR Shareholding
28th Feb 20185:32 pmRNSDirector Loan
14th Feb 20182:59 pmRNSResult of General Meeting
5th Feb 20184:22 pmRNSDirector/PDMR Shareholding
31st Jan 201812:33 pmRNSUnaudited Interim Results to 31 December 2017
19th Jan 20185:10 pmRNSNotice of General Meeting
29th Dec 201711:21 amRNSResult of AGM
7th Dec 20173:10 pmRNSNotice of AGM
7th Dec 20177:00 amRNSAudited Annual Report
1st Aug 20177:00 amRNSChange of Adviser
30th Jun 20177:01 amRNSFinance Director Retirement
30th Jun 20177:00 amRNSOrder Received
20th Apr 20174:45 pmRNSHolding(s) in Company
20th Apr 20174:03 pmRNSHolding(s) in Company
20th Apr 201711:15 amRNSHolding(s) in Company
20th Apr 201711:13 amRNSHolding(s) in Company
20th Apr 201711:11 amRNSHolding(s) in Company
18th Apr 20174:56 pmRNSTotal Voting Rights
18th Apr 201711:51 amRNSResult of GM
29th Mar 201710:00 amRNSNotice of GM
29th Mar 20177:30 amRNSResults of Placing
29th Mar 20177:00 amRNSHalf-year Report
30th Dec 201610:05 amRNSHolding(s) in Company
29th Nov 201612:19 pmRNSResult of AGM
29th Nov 201610:41 amRNSAGM Statement
7th Nov 20165:28 pmRNSNotice of AGM
25th Oct 20167:00 amRNSFinal Results
29th Sep 20163:25 pmRNSHolding(s) in Company
22nd Sep 20164:56 pmRNSHolding(s) in Company
22nd Sep 20164:54 pmRNSHolding(s) in Company
22nd Sep 20164:48 pmRNSHolding(s) in Company
16th Sep 20167:00 amRNS£750,000 Placing To Continue Growth Strategy
13th Jul 201610:47 amRNSResult of Meeting
13th Jul 20169:08 amRNSGM Statement
27th Jun 20169:42 amRNSNotice of GM
2nd Jun 20167:00 amRNSTrading Statement
3rd May 20167:00 amRNSUpdate on pilot programme
9th Feb 20167:00 amRNSHalf Yearly Report
6th Jan 20169:44 amRNSChange of name of Nominated Adviser and Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.